Renal cell carcinoma, also known by a gurnistical tumor, is the most common form of kidney cancer arising from the renal tubule. It is the most common type of kidney cancer in adults. Initial treatment is surgery. It is notoriously resistant to radiation therapy and chemotherapy, although some cases respond to immunotherapy.
CA9
the expression level of CA9 gene in
conventional RCC is related to metastasis. CA9 may be a
potential marker for the prediction of early metastasis after
nephrectomy and to guide post-operative follow-up and treatment.
PMID: 17390110
Cadherin-6
a useful
molecular marker to detect the circulating cancer cells disseminated
from conventional RCC.
PMID: 15816561
a
new prognostic marker for renal cell carcinoma.
PMID: 14665853
CD10 and RCC
are often expressed by clear cell renal cell
carcinomas, and they may be useful markers to suggest a renal
origin of carcinomas.
PMID: 16749584
Ferritin
Higher levels in
the renal vein, its positive correlation with tumor size and volume
suggest that ferritin is expressed by RCC. Initial peripheral serum
values of ferritin can be indicative of disease status and also be a
prognosticator of survival.
PMID: 10436426
may be a useful
serum marker for monitoring patients with RCC.
PMID: 7855968
a tumor marker expressed by renal cell carcinoma.
PMID: 8529738
FGF (fibroblast
growth factor)
serum basic FGF
can be useful in the diagnosis, and in evaluating the prognosis, of
patients with renal cell carcinoma.
PMID: 7730142
GGT (gamma-glutamyl transferase)
Serum
gamma glutamyl-transferase is a sensitive but unspecific marker
of metastatic renal cell carcinoma.
PMID: 17470155
HIG2
(Hypoxia-inducible protein 2)
a
novel diagnostic marker for renal cell carcinoma and potential
target for molecular therapy.
PMID: 15930302
hKIM-1 (Human
kidney injury molecule-1)
the cleaved
ectodomain of hKIM-1 can be detected in the urine of patients with
RCC and may serve as a new biomarker for early detection of RCC.
PMID: 15744000
a
useful immunohistochemical marker for diagnosing renal cell
carcinoma and ovarian clear cell carcinoma.
PMID: 17325478
IAP (immunosuppressive acidic protein)
serum IAP may serve as a tumor marker in
patients with renal cell carcinoma.
PMID: 1915542
N-cadherin
plays a different role from E-cadherin or
cadherin-6 in RCC and may be associated with the aggressiveness
and malignant potential of RCC.
PMID: 16596183
Nicotinamide N-Methyltransferase
a novel tumor marker for renal clear cell carcinoma.
PMID: 17070307
NSE (Neuron
specific enolase)
serum NSE may be considered as a useful marker in the evaluation
and surveillance of RCC.
PMID: 8836790
OPN (plasma osteopontin)
high plasma OPN levels are associated with
distant metastases and poor survival in RCC patients.
PMID: 17479289
p21
a
prognostic marker for renal cell carcinoma.
PMID: 17162001
p53
a prognostic
marker only for conventional RCC.
PMID: 15072872
PECAM-1
involvement of PECAM-1 in the process of leukocyte migration and
a potential role as a prognostic marker in renal cell carcinoma.
PMID: 8604238
RCC-Ma
(Renal cell carcinoma marker)
is
specific for cutaneous metastasis of renal cell carcinoma.
PMID: 17448192
S100A1
a
powerful marker to differentiate chromophobe renal cell
carcinoma from renal oncocytoma.
PMID: 17394501
TPS (Tissue
polypeptide specific antigen)
may have a
potential clinical role as a valuable tumor marker for RCC,
especially in advanced diseases and follow-up therapy response.
PMID: 12530023
Tu M2-PK
might be the
first tumor marker which could be an excellent complementation of
the diagnostic program for renal carcinoma.
PMID: 10470201
would appear to be a useful marker for RCC detection and
follow-up.
PMID: 10470199
Villin
a 95-kd F-actin bundling and severing
protein, is restricted in animal tissues to epithelial cells
with a brush border, may be a grading marker that deserves
further study in renal carcinoma.
PMID: 3740217
Other Renal Cell Carcinoma Markers
the serum iron level may be used as a useful
tumor marker in staging and follow-up of renal cell carcinoma.
PMID: 2007419
serum iron is a useful, inexpensive tumour
marker in selected patients with renal carcinoma.
PMID: 3801817